Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Is it possible to bring your molecule to medicine without a brick and mortar site and no testing labs or distribution capabilities? Yes. With Thermo Fisher Scientific, even start-ups have access to end-to-end drug development and manufacturing capabilities. Hear from Tom Holmes, Global Head of Supply Chain with Amylyx Pharmaceuticals, Inc., on his perspective partnering with Patheon pharma services for their outsourcing needs.